Duodenal ReCET for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease

NCT07390422 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic Syndrome (MetS)

Interventions

PROCEDURE: ReCET treatment

Sponsor

Chinese University of Hong Kong